Health Benefits of Green Coffee Bean Extract
Overview of Metabolic Syndrome
A recent study explored the health advantages of green coffee bean extract (GCE) and its potential role in managing insulin resistance and metabolic syndrome. Metabolic syndrome, often referred to as Syndrome X, encompasses a group of risk factors that elevate the likelihood of heart disease, stroke, and diabetes. This condition affects over 40% of individuals in their 60s and 70s. Key risk factors include abdominal obesity, elevated triglyceride levels, low HDL cholesterol, high blood pressure, and increased fasting blood sugar.
Current Treatments for Metabolic Syndrome
Managing metabolic syndrome is crucial for lowering the risk of heart disease and type 2 diabetes. Standard treatment approaches emphasize lifestyle changes, such as adhering to a heart-healthy diet, achieving weight loss, and increasing physical activity. While pharmacological options exist to mitigate the risk of coronary heart disease and related complications, no singular treatment effectively addresses metabolic syndrome. The side effects associated with conventional medications have spurred interest in alternative therapies, including the use of GCE for managing insulin resistance and diabetes.
Green Coffee Bean Extract and Insulin Resistance
Active Components of Green Coffee Beans
Research has shown promising effects of green coffee bean extract. The primary active constituents in coffee beans are caffeine and chlorogenic acid (CGA), a biologically active phenol that is more abundant in green coffee beans than in roasted varieties. Evidence from numerous studies indicates that GCE possesses anti-diabetic, anti-obesity, and anti-lipidemic properties. Additionally, CGA is linked to improvements in insulin resistance and reductions in blood pressure and glucose absorption.
Recent Study on Green Coffee Bean Extract
A recent investigation published in the British Journal of Nutrition examined the impact of GCE supplementation on individuals with metabolic syndrome. Conducted as a randomized, double-blind, placebo-controlled trial, the study included 43 participants aged between 18 and 70, all with a body mass index (BMI) exceeding 25 kg/m². Participants were assigned to either the intervention group, receiving 400 mg of GCE capsules (containing 186 mg of CGA) twice daily for eight weeks, or the placebo group.
Both groups followed an energy-controlled diet, with no alterations to salt intake or physical activity. Researchers assessed various anthropometric measures, including weight, waist circumference, and blood pressure, along with biochemical parameters such as fasting blood glucose and lipid profiles at both the beginning and end of the study.
Findings on Blood Glucose and Appetite Suppression
The results indicated that GCE supplementation led to significant reductions in systolic blood pressure, fasting blood glucose levels, and insulin resistance compared to the placebo group. Moreover, participants receiving GCE experienced a decrease in waist circumference and appetite scores. Weight and BMI reductions in the intervention group were observed to be double those in the placebo group. However, no significant differences in lipid profiles or glycated hemoglobin levels were found between the two groups.
These findings support previous evidence regarding the positive effects of GCE in managing metabolic syndrome. Notably, the study highlighted the importance of dosing, with participants receiving 372 mg of CGA daily, a quantity achievable through regular coffee consumption or supplementation.
Conclusion and Future Directions
Significance of the Study
This study marks a significant advancement in demonstrating GCE’s role as an appetite suppressant, contributing to weight loss alongside reductions in blood pressure, fasting glucose, and insulin resistance. Despite some limitations, such as a short intervention duration and budget constraints affecting measurement tools, the authors advocate for future research involving larger sample sizes and extended study periods to further validate the health benefits of GCE in patients with metabolic syndrome.
Overall, the study’s results align with previous animal and human research, reinforcing the potential of GCE supplementation in addressing important health concerns associated with metabolic syndrome. As an affordable and safe option, GCE may offer a valuable strategy for mitigating the health risks linked to this condition.
Written by Preeti Paul, MS Biochemistry
Reference: Hanieh Roshan et al., “Effects of Green Coffee Extract Supplementation on Anthropometric Indices, Glycaemic Control, Blood Pressure, Lipid Profile, Insulin Resistance and Appetite Control in Patients with the Metabolic Syndrome: A Randomized Clinical Trial,” British Journal of Nutrition (accessed January 2018).